BriaCell Therapeutics Unveils $8.5 Million Offering

BriaCell Therapeutics Corp., a biotechnology firm focused on developing innovative cancer immunotherapies, announced the pricing of a best-efforts offering consisting of 12,325,000 common shares or pre-funded warrants. The offering price is $0.69 per share, which includes the pre-funded warrant exercise price. This initiative is expected to generate approximately $8.5 million in gross proceeds before accounting for the placement agent’s fees and other related expenses. The closing of this offering is projected for September 12, 2024, contingent on fulfilling customary closing conditions.

The company has specified that the proceeds from this offering will be utilized for general corporate purposes, working capital needs, and to further its business objectives. ThinkEquity is serving as the sole placement agent for this offering.

The securities are being offered under a shelf registration statement on Form S-3 (File No. 333-276650), which was filed with the U.S. Securities and Exchange Commission (SEC) on January 22, 2024, and declared effective on January 31, 2024. The offering is being conducted exclusively through a written prospectus. A final prospectus supplement and the accompanying prospectus related to the offering will be filed with the SEC and can be accessed on the SEC’s website. Copies of these documents, when available, can also be obtained from ThinkEquity.

This announcement is not an invitation to buy or sell these securities, nor will there be any sale of these securities in jurisdictions where such acts would be illegal prior to registration or qualification under the relevant securities laws.

BriaCell Therapeutics Corp. is committed to advancing cancer care through its novel immunotherapy treatments. The company continues to work on transforming cancer treatment and providing new hope for patients.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!